Rankings
▼
Calendar
KLRS Q3 2023 Earnings — Kalaris Therapeutics Inc Revenue & Financial Results | Market Cap Arena
KLRS
Kalaris Therapeutics Inc
$187M
Q3 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$4M
Operating Income
-$47M
Net Income
-$44M
EPS (Diluted)
$-8.94
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$34M
Free Cash Flow
-$34M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$248M
Total Liabilities
$53M
Stockholders' Equity
$195M
Cash & Equivalents
$96M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$4M
-$199,000
-1730.7%
Operating Income
-$47M
-$43M
-9.3%
Net Income
-$44M
-$42M
-5.2%
← FY 2023
All Quarters
Q4 2023 →